Brief: Medios Says Co Acquires Ceban Pharmaceuticals B.V

Medios AG

18/03/2024 19:46

March 18 (Reuters) - Medios Ag  ILM1k.DE :
    * EQS-ADHOC: MEDIOS ACQUIRES DUTCH MARKET LEADER IN
PHARMACEUTICAL
COMPOUNDING SERVICES
    * PURCHASE PRICE CONSISTS OF A CASH COMPONENT OF EUR 235.3
MILLION
PLUS 1.7 MILLION NEW MEDIOS SHARES VALUED AT APPROX. EUR 23.9
MILLION
    * PURCHASE PRICE IS FINANCED BY MEDIOS FROM EXISTING CASH
AND A
EUR 200 MILLION COMMITTED CREDIT FACILITY
    * MEDIOS -CEBAN IS EXPECTED TO GENERATE IN 2023 REVENUE OF
C. EUR
160 MILLION AND EBITDA AFTER CERTAIN ADJUSTMENTS C. EUR 29
MILLION (EBITDA MARGIN OF C. 18%)
    * ASSUMING COMPLETION OF ACQUISITION OF CEBAN IN Q2, MEDIOS
EXPECTS REVENUE IN FY 2024 TO REACH EUR 1.9 TO EUR 2.1 BILLION
    * ASSUMING COMPLETION OF ACQUISITION OF CEBAN IN Q2, MEDIOS
EXPECTS FY 2024 EBITDA PRE^1 OF EUR 82 TO EUR 91 MILLION,

Source text for Eikon:  ID:nEQ58gqsGa 
Further company coverage:  ILM1k.DE 

 ((Reuters.Briefs@thomsonreuters.com;))